Salus BioMed

Next-Generation Sequencing Platforms

Salus offers a portfolio of next-generation sequencing (NGS) platforms designed to meet diverse throughput and application needs across research and clinical laboratories. The systems integrate proprietary optical design, rapid sequencing chemistry, and high-density chip technology to support reliable and efficient genomic analysis. Salus offers three sequencing platforms covering low- to high-throughput needs:

Saluseq Nimbo – compact benchtop system for rapid sequencing

Salus Pro – flexible mid- to high-throughput platform

Salus EVO – high-throughput production sequencer

Together, these platforms deliver high accuracy, scalable throughput, and streamlined workflows, making them well suited for academic research, clinical research, and biology laboratories.

Super-Resolution Spatial Omics

Salus Spatial Transcriptomic Solution (Salus STS) is a high-resolution, sequencing-based spatial transcriptomics platform designed to enable comprehensive gene expression profiling in the context of tissue architecture. The system integrates ultra-high-density capture chips and dedicated reagent chemistry to deliver robust and scalable spatial analysis workflows. With capture resolution approaching ~1 μm, Salus STS enables fine-scale spatial mapping of transcriptomic signals, supporting detailed investigation of cellular heterogeneity and tissue microenvironments.

The end-to-end solution is optimized for reproducibility and sensitivity, making it well suited for advanced research applications in oncology, neuroscience, developmental biology, and translational medicine. Salus STS empowers researchers to generate deeper biological insights and accelerate discovery in spatial biology.

Key Advantages

• Proprietary core technologies in NGS and spatial omics
• Sub-cellular super-resolution spatial analysis
• Scalable platform portfolio across throughput tiers
• Designed for both research and translational environments
• Rapidly expanding global partner network